Gene description for ERBB3 |
Gene name |
erb-b2 receptor tyrosine kinase 3 |
Gene symbol |
ERBB3 |
Other names/aliases |
ErbB-3 FERLK HER3 LCCS2 MDA-BF-1 VSCN1 c-erbB-3 c-erbB3 erbB3-S p180-ErbB3 p45-sErbB3 p85-sErbB3 |
Species |
Homo sapiens |
Experiment description of studies that identified ERBB3 in Serum |
1
|
Experiment ID | 973 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
22808001
|
Organism | Homo sapiens |
Experiment description | Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. |
Authors | Musante L, Saraswat M, Duriez E, Byrne B, Ravidà, Domon B, Holthofer H. |
Journal name |
PLoS One
|
Publication year | 2012 |
Sample | Serum |
Sample name | Serum -Tuberculosis patient 3 |
Isolation/purification methods | Filtration ExoQuick |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV120006: EV-METRIC:56%
|
|
|
2
|
Experiment ID | 975 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
22808001
|
Organism | Homo sapiens |
Experiment description | Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. |
Authors | Musante L, Saraswat M, Duriez E, Byrne B, Ravidà, Domon B, Holthofer H. |
Journal name |
PLoS One
|
Publication year | 2012 |
Sample | Serum |
Sample name | Serum -Tuberculosis patient 5 |
Isolation/purification methods | Filtration ExoQuick |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV120006: EV-METRIC:56%
|
|
|
3
|
Experiment ID | 976 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
22808001
|
Organism | Homo sapiens |
Experiment description | Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. |
Authors | Musante L, Saraswat M, Duriez E, Byrne B, Ravidà, Domon B, Holthofer H. |
Journal name |
PLoS One
|
Publication year | 2012 |
Sample | Serum |
Sample name | Serum -Tuberculosis patient 6 |
Isolation/purification methods | Filtration ExoQuick |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV120006: EV-METRIC:56%
|
|
|